These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30964168)

  • 1. LncRNA LACAT1 promotes proliferation of oral squamous cell carcinoma cells by inhibiting microRNA-4301.
    Wang J; Huo F; Wang XR; Xu YY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2427-2435. PubMed ID: 30964168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-378 promotes the malignant progression of oral squamous cell carcinoma by mediating FOXN3.
    Ding N; Luo M; Liao XL; Bao QY; Li RY; Wu B
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6202-6210. PubMed ID: 31364120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00657 promotes malignant progression of oral squamous cell carcinoma via regulating microRNA-150.
    Xu FY; Xu X; Hu XD
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2482-2490. PubMed ID: 32196599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
    Ye J; Jiao Y
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
    Zhang LL; Hu D; Zou LH
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
    Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
    Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
    Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
    Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2.
    Tao D; Zhang Z; Liu X; Zhang Z; Fu Y; Zhang P; Yuan H; Liu L; Cheng J; Jiang H
    Mol Carcinog; 2020 Apr; 59(4):353-364. PubMed ID: 31995261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
    Ma CX; Gao WC; Tian L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression.
    Xu D; Gu M; Liu HL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):641-648. PubMed ID: 30720172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2.
    Gao WY; Yang G; Wang J; He JM; Wang P
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
    Ni ZY; Lin FO; Liu DF; Xiao J
    Genet Mol Res; 2015 Jun; 14(2):6943-52. PubMed ID: 26125902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
    Dai J; Wei W
    Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CASC11 promotes the development of esophageal carcinoma by regulating KLF6.
    Chen SG; Wang CH; He RQ; Xu RY; Ji CB
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8878-8887. PubMed ID: 31696474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.